Letybo
Search results
Scope
Date
~
-
Bio & PharmaHugel resubmits application to FDA for botulinum toxin product
South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...
Sep 01, 2023 (Gmt+09:00)
-
Bio & PharmaHugel accelerates European botox sales with Poland's approval
Hugel Inc., South Korea’s largest maker of botulinum toxin products used to treat overactive muscles and facial wrinkles, has won sales approv...
Jun 03, 2022 (Gmt+09:00)
-
Bio & PharmaMedytox-Hugel dispute over botox strain intensifies with ITC probe
A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...
May 03, 2022 (Gmt+09:00)
1
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand
